Received Aug 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | LN8272 | IM / LL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y017527 | IM / RL |
Immediately fussy, within 8-10 minutes started developing rash, pink wheals on left medial thigh concerning for urticaria, pink papules on right buttocks, red patch on dorsum of left toes. Fussiness and rash improved during observation with pink patch remaining on left inner thigh. Observed in clinic for 20 minutes total. No dyspnea, vomiting, or other symptoms of anaphylaxis. Advised home administration of cetirizine which family administered. I (Dr.) followed up 3 hours later with family via phone, she was doing well, rash improving. She had a separate visit to the ER 8/15/25 for high fever, and on 8/18/25 was diagnosed with Roseola.
Viral upper respiratory illness within 1 month prior to vaccination
None
Vitamin D 400 IU once per day
NKDA